![]() |
市場調查報告書
商品編碼
1616721
血壓計市場機會、成長動力、產業趨勢分析與預測 2024 - 2032Sphygmomanometer Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032 |
2023 年,全球血壓計市場價值 34 億美元,由於心臟病發病率上升、技術進步以及創新產品的不斷推出,預計 2024 年至 2032 年複合年成長率為 8.5%。隨著高血壓變得越來越普遍,對準確可靠的血壓監測設備的需求不斷成長。具有自動讀數和連接功能的數位血壓計等技術創新可增強使用者體驗和資料管理。此外,設計和功能的不斷改進使這些設備更易於使用和高效,進一步推動市場在臨床和家庭環境中的擴張。
血壓計產業根據產品、操作、配置、最終用途和地區進行分類。由於其方便用戶使用的設計和更高的準確性,數位血壓計細分市場到 2023 年將達到 20 億美元。數位設備提供自動讀數,消除了手動錯誤並提供更快的結果,這使得它們對醫療保健專業人員和家庭用戶特別有吸引力。記憶體儲存、藍牙連接和易於閱讀的顯示器等功能的便利性進一步推動了它們的採用。
隨著高血壓管理意識的增強,對數位血壓計的需求可能會繼續上升,鞏固其在市場上的主導地位。手動血壓計細分市場在 2023 年創造了 14 億美元的收入,主要歸功於其長期的可靠性和成本效益。手動設備在臨床環境中經常受到青睞,允許醫療保健專業人員透過聽診獲得精確的血壓讀數,確保準確性。它們廣泛應用於易於獲得培訓和專業知識的醫院和診所。
市場範圍 | |
---|---|
開始年份 | 2023年 |
預測年份 | 2024-2032 |
起始值 | 34億美元 |
預測值 | 72 億美元 |
複合年成長率 | 8.5% |
此外,手動血壓計不需要電池或電力,使其成為各種環境下的實用選擇。可靠性和實用性的結合有助於鞏固他們在市場中的地位。北美血壓計市場在 2023 年達到 6.407 億美元,在高血壓盛行率高和心血管健康意識增強的推動下,2024 年至 2032 年將以 6.1% 的複合年成長率成長。該地區受益於先進的醫療基礎設施和廣泛的醫療技術,促進了數位和手動血壓計的採用。由於專注於創新和優質醫療保健,北美將成為血壓計行業整體成長的關鍵貢獻者。
The Global Sphygmomanometer Market was worth USD 3.4 billion in 2023 and is anticipated to exhibit an 8.5% CAGR from 2024 to 2032, attributed to the rising incidence of cardiac conditions, advancements in technology, and the ongoing launch of innovative products. As hypertension becomes increasingly common, there is a growing demand for accurate and reliable blood pressure monitoring devices. Technological innovations, such as digital sphygmomanometers with automated readings and connectivity features, enhance user experience and data management. Also, ongoing improvements in design and functionality are making these devices more accessible and efficient, further propelling the market's expansion in both clinical and home settings.
The sphygmomanometer industry is segregated based on product, operation, configuration, end-use, and region. The digital sphygmomanometer segment achieved USD 2 billion in 2023, owing to its user-friendly design and enhanced accuracy. Digital devices offer automatic readings, which eliminate manual errors and provide quicker results, making them particularly appealing for both healthcare professionals and home users. The convenience of features such as memory storage, Bluetooth connectivity, and easy-to-read displays further drives their adoption.
As awareness of hypertension management grows, the demand for digital sphygmomanometers is likely to continue rising, solidifying their dominance in the market. The manual sphygmomanometer segment generated USD 1.4 billion in 2023, primarily due to its longstanding reliability and cost-effectiveness. Often favored in clinical settings, manual devices allow healthcare professionals to take precise blood pressure readings through auscultation, ensuring accuracy. They are widely used in hospitals and clinics where training and expertise are readily available.
Market Scope | |
---|---|
Start Year | 2023 |
Forecast Year | 2024-2032 |
Start Value | $3.4 Billion |
Forecast Value | $7.2 Billion |
CAGR | 8.5% |
Besides, manual sphygmomanometers do not require batteries or electricity, making them a practical choice in various environments. This combination of reliability and practicality helps reinforce their position in the market. North America sphygmomanometer market witnessed USD 640.7 million in 2023 and will grow at a 6.1% CAGR between 2024 and 2032, driven by a high prevalence of hypertension and increased awareness of cardiovascular health. The region benefits from advanced healthcare infrastructure and widespread access to medical technologies, facilitating the adoption of both digital and manual sphygmomanometers.Furthermore, ongoing initiatives to improve chronic disease management and promote preventive healthcare are further boosting demand. With a focus on innovation and quality healthcare, North America will stand as a key contributor to the overall growth of the sphygmomanometer industry.